delta9-Tetrahydrocannabinol and the extrapyramidal system.
D000818:Animals; D001479:Basal Ganglia / Q000502:physiology; D001522:Behavior, Animal / Q000187:drug effects; D002375:Catalepsy / Q000139:chemically induced; D002421:Caudate Nucleus / Q000502:physiology; D003913:Dextroamphetamine / Q000494:pharmacology; D013759:Dronabinol / Q000494:pharmacology*; D005116:Extrapyramidal Tracts / Q000187:drug effects*; D005917:Globus Pallidus / Q000502:physiology; D006801:Humans; D008297:Male; D009043:Motor Activity / Q000187:drug effects; D010243:Paralysis / Q000139:chemically induced; D010277:Parasympathomimetics / Q000494:pharmacology; D011699:Putamen / Q000502:physiology; D051381:Rats; D013141:Spiro Compounds / Q000494:pharmacology; D013239:Stereotyped Behavior / Q000187:drug effects; D013388:Succinimides / Q000494:pharmacology
D010277:Parasympathomimetics; D013141:Spiro Compounds; D013388:Succinimides; D013759:Dronabinol; D003913:Dextroamphetamine